Continued adjuvant FOLFIRINOX for BRPC or LAPC after neoadjuvant FOLFIRINOX.
Park J, Kim HY, Na HY, Lee JS, Lee JC, Kim JW, Yoon YS, Hwang JH, Han HS, Kim J.
Park J, et al. Among authors: kim hy, kim j, kim jw.
J Cancer Res Clin Oncol. 2023 May;149(5):1765-1775. doi: 10.1007/s00432-022-04108-9. Epub 2022 Jun 20.
J Cancer Res Clin Oncol. 2023.
PMID: 35723728